Pharmaceutical

Podcast #5: Doing Digital Deals in Life Sciences | Deal Structure, Terms, and Series Conclusions

Final podcast in Sterling's series, examining how a range of factors influence transaction structure and deal terms.

Jul 24, 2024 - 04:00
Podcast #5: Doing Digital Deals in Life Sciences | Deal Structure, Terms, and Series Conclusions
Final podcast in Sterling's series, examining how a range of factors influence transaction structure and deal terms.
Read the original article

Tags:

Previous Article

Telix raises $398m to advance kidney and brain cancer radiotherapies

Next Article

Agilent agrees to acquire BIOVECTRA for $925m

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Biogen to acquire Reata Pharmaceuticals in $7 billion deal

STAT+: Biogen to acquire Reata Pharmaceuticals in $7 bi...

Jul 28, 2023

Medicare holds firm on Alzheimer’s drug coverage policy

Medicare holds firm on Alzheimer’s drug coverage policy

Jun 2, 2023

Radiopharmaceuticals reach record high with $408m in venture financing for 2023

Radiopharmaceuticals reach record high with $408m in ve...

Nov 28, 2023